Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...
It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...
If your regular shampoo and conditioner aren't quite giving you all the shine and frizz control you're looking for, you may need to call in a pinch hitter: a hair gloss. These innovative ...
Anti-aging advocate Bryan Johnson, who gulps down 54 pills for breakfast, recently discovered a wrinkle in his meticulous approach to dodging death. Every two weeks, the 47-year-old tech ...
The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.
Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...
Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...
NEW BRUNSWICK, N.J. and BEDMINSTER, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced ...
What's the first thing you notice about someone? For some, it's their hair, whether that be the length, texture, color or shine. On average, there are approximately 100,000 hair follicles on the ...
Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...
The Houston Texans on Tuesday waived wide receiver Diontae Johnson as they prepare for their divisional-round playoff game on Saturday against the Kansas City Chiefs. "Unfortunately, with Diontae ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback